# 🧠 Radiomics-Clinical Research Roadmap
## Comprehensive Analysis Plan for Your mRS Dataset

### 📊 **Dataset Overview**
- **132 patients** with complete radiomics + clinical data
- **535 radiomics features** from 5 MRI modalities (T1, T2, FLAIR, DWI, ADC)
- **143 clinical features** including mRS scores, demographics, comorbidities
- **5 years of data** (2020-2024)
- **Data quality**: 88.5% completeness

---

## 🎯 **IMMEDIATE RESEARCH OPPORTUNITIES**

### 1️⃣ **mRS Prediction Models** ⭐ **HIGHEST PRIORITY**

#### **A. 90-Day mRS Prediction** (128 patients available)
- **Current Results**: AUC = 0.621 (Random Forest)
- **Class Distribution**: 57.3% Good outcome (mRS 0-2) vs 42.7% Poor outcome (mRS 3-5)
- **Top Features**: T1 minimum intensity, ADC minimum, T1 texture features

**Next Steps:**
- Implement ensemble methods (XGBoost, CatBoost)
- Add feature engineering (interaction terms)
- Use SHAP for interpretability
- Cross-validate with different splits

#### **B. Last mRS Prediction** (128 patients available)
- Similar sample size to 90-day
- Longer-term outcome prediction
- Compare with 90-day model performance

#### **C. Multi-class mRS Prediction**
- Predict all mRS levels (0-5)
- Ordinal regression approaches
- Compare with binary classification

### 2️⃣ **Radiomics-Clinical Correlations** 🔬

#### **A. Age-Related Analysis**
- **Available**: 132 patients, mean age 63.3±14.5
- **Young vs Elderly**: 59 patients <65, 73 patients ≥65
- **Research Questions**:
  - Do radiomics features differ by age?
  - Age-specific prediction models
  - Age as a modifier of radiomics-mRS relationship

#### **B. Sex Differences**
- **Available**: 132 patients with sex data
- **Research Questions**:
  - Sex-specific radiomics patterns
  - Different prediction models for males vs females
  - Sex as a confounding variable

#### **C. Comorbidity Effects**
- **Available**: Diabetes, Hypertension, AFIB, Prior Stroke, Smoking history
- **Research Questions**:
  - How comorbidities affect radiomics features
  - Comorbidity-adjusted prediction models
  - Interaction between radiomics and clinical risk factors

### 3️⃣ **Multi-Modal Radiomics Analysis** 📈

#### **A. Modality Comparison**
- **5 modalities**: T1, T2, FLAIR, DWI, ADC (107 features each)
- **Research Questions**:
  - Which modality is most predictive?
  - Optimal modality combinations
  - Cross-modal feature correlations

#### **B. Feature Fusion Strategies**
- Early fusion (concatenate all features)
- Late fusion (separate models, combine predictions)
- Intermediate fusion (modality-specific layers)

### 4️⃣ **Temporal Analysis** 📅

#### **A. Year-to-Year Variations**
- **5 years**: 2020-2024
- **Research Questions**:
  - Has patient population changed over time?
  - Treatment protocol evolution effects
  - Seasonal patterns in outcomes

---

## 🚀 **ADVANCED RESEARCH DIRECTIONS**

### 5️⃣ **Feature Selection & Dimensionality Reduction**

#### **A. Statistical Feature Selection**
- LASSO/Ridge regression
- Recursive Feature Elimination (RFE)
- Principal Component Analysis (PCA)
- Independent Component Analysis (ICA)

#### **B. Machine Learning Feature Selection**
- SHAP values for feature importance
- Permutation importance
- Boruta algorithm
- Stability selection

### 6️⃣ **Advanced Machine Learning**

#### **A. Ensemble Methods**
- Random Forest (already tested: AUC = 0.621)
- XGBoost
- CatBoost
- Voting classifiers
- Stacking

#### **B. Deep Learning Approaches**
- Neural networks for radiomics
- Autoencoders for feature learning
- Transfer learning from medical imaging models

#### **C. Multi-Task Learning**
- Predict multiple outcomes simultaneously
- 90-day mRS + Last mRS + Baseline mRS
- Shared feature learning

### 7️⃣ **Clinical Translation**

#### **A. Risk Stratification Models**
- High/Medium/Low risk categories
- Clinical decision support system
- Personalized treatment recommendations

#### **B. Prognostic Biomarker Discovery**
- Identify most predictive radiomics features
- Clinical-radiomics composite scores
- Biomarker validation

### 8️⃣ **Validation & Generalization**

#### **A. Robust Validation**
- 10-fold cross-validation
- Leave-one-out cross-validation
- Bootstrap validation
- External validation (if possible)

#### **B. Model Interpretability**
- SHAP explanations
- LIME for local explanations
- Feature importance visualization
- Clinical correlation analysis

---

## 📋 **IMPLEMENTATION PRIORITY LIST**

### **Phase 1: Foundation (Weeks 1-2)**
1. ✅ **Complete**: Basic mRS prediction (AUC = 0.621)
2. **Next**: Improve model performance with ensemble methods
3. **Next**: Feature importance analysis with SHAP
4. **Next**: Cross-validation with different strategies

### **Phase 2: Exploration (Weeks 3-4)**
1. **Radiomics-clinical correlations**
2. **Multi-modal analysis**
3. **Age and sex subgroup analysis**
4. **Feature selection optimization**

### **Phase 3: Advanced (Weeks 5-6)**
1. **Deep learning approaches**
2. **Multi-task learning**
3. **Temporal analysis**
4. **Clinical translation**

### **Phase 4: Validation (Weeks 7-8)**
1. **Robust validation strategies**
2. **Model interpretability**
3. **Clinical expert validation**
4. **Publication preparation**

---

## 🎯 **SPECIFIC ANALYSIS RECOMMENDATIONS**

### **Immediate Actions (This Week):**

1. **Improve Current Model**:
   ```python
   # Try XGBoost and CatBoost
   # Add feature engineering
   # Implement SHAP analysis
   # Use stratified cross-validation
   ```

2. **Feature Importance Analysis**:
   - Analyze top 10 features already identified
   - Group by modality (T1, T2, FLAIR, DWI, ADC)
   - Group by feature type (shape, texture, intensity)

3. **Subgroup Analysis**:
   - Age groups (<65 vs ≥65)
   - Sex-specific models
   - Comorbidity subgroups

### **Medium-term Goals (Next 2-4 weeks):**

1. **Multi-modal Analysis**:
   - Compare modality performance
   - Find optimal modality combinations
   - Cross-modal correlations

2. **Clinical Integration**:
   - Radiomics + clinical composite scores
   - Risk stratification models
   - Treatment response prediction

### **Long-term Vision (Next 2-3 months):**

1. **Clinical Decision Support System**
2. **Personalized Medicine Approaches**
3. **Multi-center Validation**
4. **Publication in High-Impact Journals**

---

## 📊 **CURRENT RESULTS SUMMARY**

### **mRS Prediction Performance**:
- **Model**: Random Forest
- **AUC**: 0.621
- **Accuracy**: 55%
- **Sample Size**: 128 patients
- **Class Balance**: 57.3% Good vs 42.7% Poor outcome

### **Top Predictive Features**:
1. T1_original_firstorder_Minimum
2. ADC_original_firstorder_Minimum
3. T1_original_glcm_Idmn
4. DWI_original_shape_Maximum2DDiameterSlice
5. T2_original_ngtdm_Busyness

### **Data Quality**:
- **Completeness**: 88.5%
- **Missing Values**: 10,349 out of 89,892 cells
- **Modalities**: All 5 available for all patients

---

## 🎉 **CONCLUSION**

Your dataset is **excellent** for radiomics research with:
- ✅ **Sufficient sample size** (132 patients)
- ✅ **High-quality radiomics** (535 features from 5 modalities)
- ✅ **Rich clinical data** (143 features)
- ✅ **Multiple outcomes** (4 mRS timepoints)
- ✅ **Good data quality** (88.5% completeness)

**Next immediate step**: Improve the current model performance and explore the rich feature set you have available!

---

*This roadmap provides a structured approach to maximize the research potential of your radiomics-clinical dataset.* 